Clinical Trial

Effects of Cannabis Species Labeling and Marketing on Perceptual, Subjective and Objective Use Outcomes (Aim 2 Study)

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
This study looks at how cannabis product label and marketing claims affect product perceptions, use expectancies, and use intentions among inexperienced and experienced cannabis users. Participants will answer online survey questions on their perceptions of a cannabis product advertisement.
Protocol Amendment History 3 changes
notable Primary completion pushed: 2026-07 -> 2026-08 2026-07-17
minor Completion pushed: 2026-07 -> 2026-08 2026-07-17
critical Trial status changed: Not Yet Recruiting → Enrolling by Invitation 2026-05-12
Trial Details
NCT Number NCT07513337
Lead Sponsor Johns Hopkins Bloomberg School of Public Health
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions Cannabis Use
Enrollment 2,000 participants
Start Date 2026-04-15
Primary Completion 2026-08 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2026-07-20